Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 781 AL 795

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence

Storelli E, Cassina N, Rasini E, Marino F, Cosentino M.

Front Neurol. 2019 Jan 24;10:13. doi: 10.3389/fneur.2019.00013. eCollection 2019.

Epigenetic and Neurological Impairments Associated with Early Life Exposure to Persistent Organic Pollutants

Grova N, Schroeder H, Olivier JL, Turner JD.

Int J Genomics. 2019 Jan 14;2019:2085496. doi: 10.1155/2019/2085496. eCollection 2019.

Tactile hallucinations in dementia with Lewy bodies

Ukai K.

Psychogeriatrics. 2019 Sep;19(5):435-439. doi: 10.1111/psyg.12407. Epub 2019 Feb 7.

Promising potentials of Tibetan macaques in xenotransplantation

Zheng H, Liu T, Lei T, Girani L, Wang Y, Deng S.

Xenotransplantation. 2019 Jan;26(1):e12489. doi: 10.1111/xen.12489. Epub 2019 Feb 8.

The role of wearables in spinal posture analysis: a systematic review

Simpson L, Maharaj MM, Mobbs RJ.

BMC Musculoskelet Disord. 2019 Feb 8;20(1):55. doi: 10.1186/s12891-019-2430-6.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8.

Is outcome of subthalamic nucleus deep brain stimulation in Parkinson disease predictable?

Chen CC.

Neurology. 2019 Mar 5;92(10):453-454. doi: 10.1212/WNL.0000000000007023. Epub 2019 Feb 8.

Dissecting α-synuclein inclusion pathology diversity in multiple system atrophy: implications for the prion-like transmission hypothesis

Dhillon JS, Trejo-Lopez JA, Riffe C, McFarland NR, Hiser WM, Giasson BI, Yachnis AT.

Lab Invest. 2019 Jul;99(7):982-992. doi: 10.1038/s41374-019-0198-9. Epub 2019 Feb 8.

Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH.

BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3.

Co-morbid demyelinating lesions and atypical clinical features in a patient with Parkinson's disease

Rodriguez-Diehl R, Vilas D, Bargalló N, Tolosa E, Gelpi E.

Parkinsonism Relat Disord. 2019 May;62:242-245. doi: 10.1016/j.parkreldis.2019.01.015. Epub 2019 Feb 2.

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T; Parkinson's Progression Markers InitiativeSteering Committee; Study Cores; Site Investigators; Coordinators; Industry and Scientific Advisory Board.

Parkinsonism Relat Disord. 2019 May;62:201-209. doi: 10.1016/j.parkreldis.2018.12.025. Epub 2019 Jan 31.

Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity

Höllerhage M, Bickle M, Höglinger GU.

Curr Neurol Neurosci Rep. 2019 Feb 9;19(2):8. doi: 10.1007/s11910-019-0925-z.

Peroxisomal dysfunction in neurodegenerative diseases

Jo DS, Cho DH.

Arch Pharm Res. 2019 May;42(5):393-406. doi: 10.1007/s12272-019-01131-2. Epub 2019 Feb 9.

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease

Zhou ZD, Selvaratnam T, Lee JCT, Chao YX, Tan EK.

Transl Neurodegener. 2019 Feb 4;8:6. doi: 10.1186/s40035-019-0145-0. eCollection 2019.

Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease

Doi H, Sakakibara R, Masuda M, Tateno F, Aiba Y, Kishi M, Yamanishi T, Yamamoto T, Matsuoka K.

Clin Auton Res. 2019 Dec;29(6):633-638. doi: 10.1007/s10286-019-00597-w. Epub 2019 Feb 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias